Results 131 to 140 of about 229,291 (168)

A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern. [PDF]

J Infect Dis
Dolange V, Slamanig S, Abdeljawad A, Lai TY, Lemus N, Singh G, Carreño JM, Abbad A, Srivastava K, Simon V, Sachithanandham J, Pekosz A, Sullivan D, Krammer F, Sun W, Palese P, González-Domínguez I.   +16 more
europepmc   +1 more source

A First Case Report of Autoimmune Acquired Factor V Deficiency After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination at the Time of Initiating Haemodialysis. [PDF]

Nephrology (Carlton)
Tasaki A, Fukuda A, Kudo A, Nishikawa E, Koumatsu N, Wada M, Okita J, Maruo M, Uchida H, Nakata T, Itani K, Shibata H.   +11 more
europepmc   +1 more source

Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses. [PDF]

PLoS Pathog
Gilbert-Girard S, Piret J, Carbonneau J, Hénaut M, Goyette N, Boivin G.   +5 more
europepmc   +1 more source

Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review). [PDF]

Mol Med Rep
Zhang T, Yang D, Tang L, Hu Y.
europepmc   +1 more source

Increased pathogenicity and transmissibility in hamsters of all age groups reveal an underestimated perniciousness of severe acute respiratory syndrome coronavirus 2 EG.1 variant. [PDF]

iScience
Zhou M, Ma J, Fang M, Liu X, Zhang C, Wu K, Ye J, Zhang Y, Yuan Q, Chen R, Chen P, Zhu H, Guan Y, Cheng T, Yuan L, Xia N.   +15 more
europepmc   +1 more source

Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance Mutations. [PDF]

J Infect Dis
Zhou S, Long N, Rosenke K, Jarvis MA, Feldmann H, Swanstrom R.   +5 more
europepmc   +1 more source

A population-representative serosurvey estimating vaccine-induced immunity against measles, rubella, hepatitis B and severe acute respiratory syndrome coronavirus 2 in Timor-Leste. [PDF]

Lancet Reg Health Southeast Asia
Arkell P, Tanesi MY, Martins N, Gomes N, Oakley T, Solano V, David M, Amaral S, Sheridan SL, Yip TW, Draper ADK, Sarmento N, Soares da Silva E, Alves L, Nicholson S, Stambos V, Pedrina K, Freitas C, de Neri Machado F, Gusmão CA, da Costa Barreto I, Fancourt NSS, Macartney K, Yan J, Francis JR.   +24 more
europepmc   +1 more source

In silico exploration of natural xanthone derivatives as potential inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication and cellular entry. [PDF]

J Comput Aided Mol Des
Obakachi VA, Nchiozem-Ngnitedem VA, Govender KK, Govender PP.   +3 more
europepmc   +1 more source

Positive impact of nutrition in the prevention of peripheral vascular disease and severe acute respiratory syndrome coronavirus 2: review. [PDF]

Front Nutr
Karim ZA, Reese RA, Smith AN, Blackadar ME, Arora V, Moore NM, Johnson EA.   +6 more
europepmc   +1 more source